UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012476
Receipt number R000010886
Scientific Title Investigation of the effect of administration period of edoxaban on the venous thromboembolism prophylaxis and the side effect
Date of disclosure of the study information 2013/12/03
Last modified on 2020/12/15 19:04:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of the effect of administration period of edoxaban on the venous thromboembolism prophylaxis and the side effect

Acronym

Effect of administration period of edoxaban on the VTA and the side effect

Scientific Title

Investigation of the effect of administration period of edoxaban on the venous thromboembolism prophylaxis and the side effect

Scientific Title:Acronym

Effect of administration period of edoxaban on the VTA and the side effect

Region

Japan


Condition

Condition

Fracture of proximal femur

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investihgate the appropriate administration period of edoxaban in older patients with fractures of proximal femur

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To evaluuate the incidence of venous thromboembolism prophylaxis after administration of edoxaban at post-operative days 8 and 15

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

7-day Edoxaban administration

Interventions/Control_2

14-day Edoxaban administration

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

-Patients with fractures with proximal femur
-Patients whom operation is performed witinh 7 days after fractures

Key exclusion criteria

Patinets
-whose body weight is less than 40 kg
-who have renal dysfunction
-who is taking anti platelet agents
-who is taking anticoagulants
-whom anticoagulants is administrated before operation
-whos has high risk of bleeding

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Sang Yang
Middle name
Last name Lee

Organization

Kobe University Hospital

Division name

Department of Orthopaedic Surgery

Zip code

650-0018

Address

7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Japan

TEL

078-382-5985

Email

sangyang@beige.plala.or.jp


Public contact

Name of contact person

1st name Sang Yang
Middle name
Last name Lee

Organization

Kobe University Hospital

Division name

Department of Orthopaedic Surgery

Zip code

6500018

Address

7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Japan

TEL

078-382-5985

Homepage URL


Email

sangyang@beige.plala.or.jp


Sponsor or person

Institute

Sang Yang Lee

Institute

Department

Personal name



Funding Source

Organization

Department of Orthopaedic Surgery, Kobe University Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kobe University Hospital

Address

7-5-2 Kusunoki-cho, Chuo-ku, Kobe, Japan

Tel

078-382-6669

Email

chiken@med.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

神戸大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2013 Year 12 Month 03 Day


Related information

URL releasing protocol

NA

Publication of results

Unpublished


Result

URL related to results and publications

NA

Number of participants that the trial has enrolled


Results

Deceased

Results date posted

2019 Year 12 Month 10 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

NA

Participant flow

NA

Adverse events

NA

Outcome measures

NA

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2013 Year 12 Month 03 Day

Date of IRB

2013 Year 12 Month 01 Day

Anticipated trial start date

2013 Year 12 Month 03 Day

Last follow-up date

2017 Year 03 Month 31 Day

Date of closure to data entry

2017 Year 03 Month 31 Day

Date trial data considered complete

2017 Year 03 Month 31 Day

Date analysis concluded

2017 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2013 Year 12 Month 03 Day

Last modified on

2020 Year 12 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010886


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name